– USA, PA – Suvoda LLC, a global clinical trial technology company that specializes in complex studies in therapeutic areas like oncology, central nervous system, and rare disease, today announced the appointment of Irena Webster to its Board of Directors.
About Irena Lerentracht Webster
Irena Webster is a seasoned global drug development leader with over two decades of experience at sponsor, CRO, and site levels. She has led global clinical trial strategy and execution in myriad therapeutic areas, including neurology, psychiatry, oncology, cardiology, and rare disease, contributing to multiple NDAs and sNAs.
Webster currently serves as VP of head of program strategy & development operations for Arkuda Therapeutics, a biotechnology company that focuses on neurodegenerative disease. Before that, she led the Clinical Operations and Biometrics teams at FORMA Therapeutics (now a Novo Nordisk company) through a global sickle cell program as well as the approval of olutasidanib for the treatment of IDH1 mutation Acute Myeloid Leukemia. She also has held senior clinical development and operations roles at Sage Therapeutics and Alkermes.
In addition to joining the board of directors, Webster also serves on the Suvoda customer advisory board.
“Suvoda has a culture of authenticity, curiosity, passion, and excellence which is instantly apparent to customers. Leadership is extraordinarily customer-centric, interested in understanding and engaging, in helping someone like me, in the role of a sponsor, do my job better,” said Irena Webster. “These characteristics and culture are the elements that motivated me to accept when I was asked to join the board. I am proud to be collaborating with some of the brightest minds in the eClinical space to make a difference in how clinical trial teams serve patients.”
Irena Webster earned her master’s in public health from New York Medical College.
About Suvoda
Suvoda is a global clinical trial technology company specializing in complex, life-sustaining studies in therapeutic areas like oncology, central nervous system, and rare disease. Founded in 2013 by experts in eClinical technologies, Suvoda empowers clinical trial professionals to manage the most urgent moments in the most urgent trials through advanced software solutions delivered on a single platform. Headquartered outside Philadelphia, Suvoda also maintains offices in Portland, OR; Barcelona, Spain; Bucharest, Romania; and Tokyo, Japan. The company consistently boasts a Net Promoter Score of close to 70, far exceeding the technology industry average of 50, and has been selected by trial sponsors and CROs to support more than 1,000 trials across 80 countries.
For more information: https://www.suvoda.com/
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.
